{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:12:55Z","timestamp":1747195975879,"version":"3.40.5"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Commission H2020 FTI","award":["737964"],"award-info":[{"award-number":["737964"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Critical limb ischaemia is a severe stage of lower limb peripheral artery disease which can lead to tissue loss, gangrene, amputation and death. FlowOx\u2122 therapy is a novel negative-pressure chamber system intended for home use to increase blood flow, reduce pain and improve wound healing for patients with peripheral artery disease and critical limb ischaemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A Markov model was constructed to assess the relative cost-effectiveness of FlowOx\u2122 therapy compared to standard care in lower limb peripheral artery disease patients with intermittent claudication or critical limb ischaemia. The model used data from two European trials of FlowOx\u2122 therapy and published evidence on disease progression. From an NHS analysis perspective, various FlowOx\u2122 therapy scenarios were modelled by adjusting the dose of FlowOx\u2122 therapy and the amount of other care received alongside FlowOx\u2122 therapy, in comparison to standard care.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In the base case analysis, consisting of FlowOx\u2122 therapy plus nominal care, the cost estimates were \u00a312,704 for a single dose of FlowOx\u2122 therapy per annum as compared with \u00a315,523 for standard care. FlowOx\u2122 therapy patients gained 0.27 additional quality adjusted life years compared to standard care patients. This equated to a dominant incremental cost-effectiveness ratio per QALY gained. At the NICE threshold WTP of \u00a320,000 and \u00a330,000 per QALY gained, FlowOx\u2122 therapy in addition to standard care had a 0.80 and 1.00 probability of being cost-effectiveness respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>FlowOx\u2122 therapy delivered as a single annual dose may be a cost-effective treatment for peripheral artery disease. FlowOx\u2122 therapy improved health outcomes and reduced treatment costs in this modelled cohort. The effectiveness and cost-effectiveness of FlowOx\u2122 therapy is susceptible to disease severity, adherence, dose and treatment cost. Research assessing the impact of FlowOx\u2122 therapy on NHS resource use is needed in order to provide a definitive economic evaluation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0244851","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T19:44:30Z","timestamp":1610653470000},"page":"e0244851","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-8942","authenticated-orcid":true,"given":"Victory \u2018Segun","family":"Ezeofor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Bryning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farina","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-1614","authenticated-orcid":true,"given":"Henrik","family":"Hoel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhiannon Tudor","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"pone.0244851.ref001","article-title":"Ankle brachial index for the diagnosis of lower limb peripheral arterial disease\u2014Crawford, F\u20142016 | Cochrane Library.","author":"F Crawford","year":"2016","journal-title":"Cochrane Database of Systematic Reviews."},{"issue":"1","key":"pone.0244851.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).","volume":"45","author":"L Norgren","year":"2007","journal-title":"Journal of Vascular Surgery"},{"issue":"4","key":"pone.0244851.ref003","first-page":"529","article-title":"Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.","volume":"55","author":"F Sartipy","year":"2018"},{"issue":"1","key":"pone.0244851.ref004","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1186\/s13063-017-2358-9","article-title":"Development of a core outcome set for studies involving patients undergoing major lower limb amputation for peripheral arterial disease: study protocol for a systematic review and identification of a core outcome set using a Delphi survey","volume":"18","author":"GK Ambler","year":"2017","journal-title":"Trials"},{"issue":"1","key":"pone.0244851.ref005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(03)00204-1","article-title":"High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study","volume":"172","author":"C Diehm","year":"2004","journal-title":"Atherosclerosis"},{"volume-title":"Cardiovascular Disease and the Use of Swedish Health Care Registries and Electronic Medical Data From Primary Care: Disease Reality, Risk Factors, Comparative Effectiveness and Outcomes","year":"2018","author":"LP Hasvold","key":"pone.0244851.ref006"},{"key":"pone.0244851.ref007","article-title":"Peripheral artery disease","volume":"360","author":"RL Morley","year":"2018","journal-title":"BMJ"},{"key":"pone.0244851.ref008","unstructured":"NICE. Peripheral arterial disease: diagnosis and management. Clinical guidline [CG147] London: NICE; 2012 [Available from: https:\/\/www.nice.org.uk\/guidance\/cg147\/documents\/lower-limb-peripheral-arterial-disease-guideline-review-full-guideline2."},{"issue":"11","key":"pone.0244851.ref009","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2337\/dc16-0850","article-title":"Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials","volume":"39","author":"MI Spreen","year":"2016","journal-title":"Diabetes care"},{"issue":"7870","key":"pone.0244851.ref010","first-page":"42","article-title":"Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance","volume":"345","author":"J Layden","year":"2012","journal-title":"British Medical Journal"},{"issue":"8","key":"pone.0244851.ref011","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/dme.13973","article-title":"The cost of diabetic foot ulcers and amputations to the National Health Service in England","volume":"36","author":"M Kerr","year":"2019","journal-title":"Diabetic Medicine"},{"issue":"8","key":"pone.0244851.ref012","doi-asserted-by":"crossref","first-page":"e0182081","DOI":"10.1371\/journal.pone.0182081","article-title":"Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review.","volume":"12","author":"M Narres","year":"2017","journal-title":"PloS one."},{"issue":"1","key":"pone.0244851.ref013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13643-015-0064-9","article-title":"Incidence of lower extremity amputation in the diabetic compared to the non-diabetic population: a systematic review protocol.","volume":"4","author":"T Kvitkina","year":"2015","journal-title":"Systematic reviews."},{"issue":"7238","key":"pone.0244851.ref014","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/bmj.320.7238.854","article-title":"Chronic lower limb ischemia","volume":"320","author":"JD Beard","year":"2000","journal-title":"BMJ"},{"issue":"19 Suppl","key":"pone.0244851.ref015","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjon.2000.9.Sup3.12483","article-title":"The cost-effectiveness of wound management protocols of care.","volume":"9","author":"K Harding","year":"2000","journal-title":"British journal of nursing (Mark Allen Publishing)."},{"issue":"9368","key":"pone.0244851.ref016","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(03)13169-8","article-title":"Diabetic foot ulcers","volume":"361","author":"WJ Jeffcoate","year":"2003","journal-title":"The Lancet"},{"key":"pone.0244851.ref017","first-page":"57","article-title":"Development of a framework for pneumatic device selection for lymphedema treatment","volume":"2","author":"SM Maul","year":"2009","journal-title":"Medical Devices (Auckland, NZ)."},{"issue":"5","key":"pone.0244851.ref018","first-page":"631","article-title":"Effects of vacuum-compression therapy on healing of diabetic foot ulcers: Randomized controlled trial. Journal of Rehabilitation Research &","volume":"44","author":"A Akbari","year":"2007","journal-title":"Development"},{"issue":"3","key":"pone.0244851.ref019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bjps.2011.08.010","article-title":"Application of low-pressure negative pressure wound therapy to ischaemic wounds","volume":"65","author":"Y Kasai","year":"2012","journal-title":"Journal of Plastic, Reconstructive & Aesthetic Surgery."},{"key":"pone.0244851.ref020","article-title":"A systematic review of patient progression in peripheral arterial disease and lower extremity amputation in building evidence for an economic model: study protocol.:","volume":"2019","author":"V Ezeofor","year":"2019","journal-title":"PROSPERO"},{"issue":"9901","key":"pone.0244851.ref021","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"FGR Fowkes","year":"2013","journal-title":"The lancet"},{"issue":"5","key":"pone.0244851.ref022","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jvs.2013.11.063","article-title":"Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes","volume":"59","author":"T Mueller","year":"2014","journal-title":"Journal of Vascular Surgery"},{"key":"pone.0244851.ref023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jvs.2012.01.054","article-title":"Long-term limb salvage and survival after endovascular and open revascularization for critical limb ischemia after adoption of endovascular-first approach by vascular surgeons","volume":"563","author":"HH Dosluoglu","year":"2012","journal-title":"Journal of vascular surgery"},{"issue":"4","key":"pone.0244851.ref024","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","article-title":"An Introduction to Markov Modelling for Economic Evaluation.","volume":"13","author":"A Briggs","year":"1998","journal-title":"PharmacoEconomics."},{"issue":"3","key":"pone.0244851.ref025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10198-003-0205-2","article-title":"When Should Decision-Analytic Modeling Be Used in the Economic Evaluation of Health Care?","volume":"4","author":"U Siebert","year":"2003","journal-title":"The European Journal of Health Economics"},{"issue":"2","key":"pone.0244851.ref026","first-page":"e001946","article-title":"Management of Critical Limb Ischemia.","volume":"9","author":"S Kinlay","year":"2016","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"2","key":"pone.0244851.ref027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia","volume":"19","author":"A Dua","year":"2016","journal-title":"Techniques in vascular and interventional radiology"},{"issue":"9","key":"pone.0244851.ref028","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0003319715626849","article-title":"Low Rates of Revascularization and High In-Hospital Mortality in Patients With Ischemic Lower Limb Amputation: Morbidity and Mortality of Ischemic Amputation.","volume":"67","author":"NM Malyar","year":"2016","journal-title":"Angiology"},{"issue":"3","key":"pone.0244851.ref029","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2337\/diacare.29.03.06.dc05-1992","article-title":"Risk of Reamputation in Diabetic Patients Stratified by Limb and Level of Amputation: A 10-year observation","volume":"29","author":"Y Izumi","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"pone.0244851.ref030","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.jfas.2017.06.004","article-title":"Predictors of Lower Extremity Amputation and Reamputation Associated With the Diabetic Foot.","volume":"56","author":"E Acar","year":"2017","journal-title":"The journal of foot and ankle surgery"},{"key":"pone.0244851.ref031","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2147\/VHRM.S6759","article-title":"Ankle brachial pressure index (ABPI): An update for practitioners.","volume":"5","author":"M Al-Qaisi","year":"2009","journal-title":"Vascular health and risk management."},{"issue":"11","key":"pone.0244851.ref032","doi-asserted-by":"crossref","first-page":"e016030","DOI":"10.1136\/bmjopen-2017-016030","article-title":"Progression of disease preceding lower extremity amputation in Denmark: a longitudinal registry study of diagnoses, use of medication and healthcare services 14 years prior to amputation","volume":"7","author":"PS Jensen","year":"2017","journal-title":"BMJ open"},{"key":"pone.0244851.ref033","unstructured":"NHS I. National Schedule of Reference Costs 2018 London: NHS Improvement; 2018 [Available from: https:\/\/improvement.nhs.uk\/resources\/reference-costs\/#rc1718."},{"issue":"12","key":"pone.0244851.ref034","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/dme.12545","article-title":"Cost of diabetic foot disease to the National Health Service in England","volume":"31","author":"M Kerr","year":"2014","journal-title":"Diabetic Medicine"},{"issue":"2","key":"pone.0244851.ref035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejvs.2018.03.007","article-title":"Hospital and Institutionalisation Care Costs after Limb and Visceral Ischaemia Benchmarked Against Stroke: Long-Term Results of a Population Based Cohort Study.","volume":"56","author":"R Luengo-Fernandez","year":"2018","journal-title":"European Journal of Vascular & Endovascular Surgery."},{"journal-title":"Unit Costs of Health and Social Care 2018","year":"2018","author":"L Curtis","key":"pone.0244851.ref036"},{"issue":"8","key":"pone.0244851.ref037","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s11136-019-02166-0","article-title":"Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments.","volume":"28","author":"S Petersohn","year":"2019","journal-title":"Quality of Life Research"},{"issue":"10","key":"pone.0244851.ref038","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).","volume":"20","author":"M Herdman","year":"2011","journal-title":"Quality of Life Research."},{"issue":"7","key":"pone.0244851.ref039","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","article-title":"Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.","volume":"22","author":"M Janssen","year":"2013","journal-title":"Quality of Life Research"},{"issue":"6719","key":"pone.0244851.ref040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"JN Matthews","year":"1990","journal-title":"BMJ (Clinical research ed)."},{"issue":"5","key":"pone.0244851.ref041","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial\u2010based cost\u2010effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"A Manca","year":"2005","journal-title":"Health Economics"},{"key":"pone.0244851.ref042","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials Oxford: OUP; 2014 [Available from: https:\/\/pdfs.semanticscholar.org\/c26a\/41e3d738c3c3c03e3796fafabbbb214465cd.pdf."},{"issue":"7","key":"pone.0244851.ref043","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","article-title":"Discounting in Economic Evaluations.","volume":"36","author":"A Attema","year":"2018","journal-title":"PharmacoEconomics."},{"key":"pone.0244851.ref044","unstructured":"NICE. Medical technologies evaluation programme methods guide. Process and methods [PMG33] London: NICE; 2017 [Available from: https:\/\/www.nice.org.uk\/process\/pmg33\/chapter\/introduction."},{"issue":"4","key":"pone.0244851.ref045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40273-015-0327-2","article-title":"AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.","volume":"34","author":"P Vemer","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"pone.0244851.ref046","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0266462313000160","article-title":"CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT.","volume":"29","author":"D Husereau","year":"2013","journal-title":"International journal of technology assessment in health care"},{"issue":"1","key":"pone.0244851.ref047","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2288-12-168","article-title":"Reporting guidelines for modelling studies.","volume":"12","author":"C Bennett","year":"2012","journal-title":"BMC medical research methodology."},{"issue":"36","key":"pone.0244851.ref048","first-page":"iii","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment.","volume":"8","author":"Z Philips","year":"2004","journal-title":"Health technology assessment (Winchester, England)."},{"issue":"1","key":"pone.0244851.ref049","first-page":"58","article-title":"Wound Healing Potential of Intermittent Negative Pressure under Limited Access Dressing in Burn Patients: Biochemical and Histopathological Study.","volume":"7","author":"HT Muguregowda","year":"2018","journal-title":"World journal of plastic surgery"},{"issue":"3","key":"pone.0244851.ref050","first-page":"265","article-title":"Superficial burn wound healing with intermittent negative pressure wound therapy under limited access and conventional dressings","volume":"5","author":"TM Honnegowda","year":"2016","journal-title":"World journal of plastic surgery"},{"issue":"20","key":"pone.0244851.ref051","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.14814\/phy2.12998","article-title":"The effects of intermittent negative pressure on the lower extremities' peripheral circulation and wound healing in four patients with lower limb ischemia and hard\u2010to\u2010heal leg ulcers: a case report.","volume":"4","author":"\u00d8H Sundby","year":"2016","journal-title":"Physiological reports"},{"issue":"17","key":"pone.0244851.ref052","doi-asserted-by":"crossref","first-page":"e12911","DOI":"10.14814\/phy2.12911","article-title":"Application of intermittent negative pressure on the lower extremity and its effect on macro\u2010and microcirculation in the foot of healthy volunteers","volume":"4","author":"\u00d8H Sundby","year":"2016","journal-title":"Physiological Reports"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T19:45:02Z","timestamp":1610653502000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244851"}},"subtitle":[],"editor":[{"given":"Raffaele","family":"Serra","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0244851","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,1,14]]}}}